juna.ai | $7,500,000 | (Nov 21, 2024)
Distru | $6,000,000 | (Nov 21, 2024)
CellPoint Digital | $30,000,000 | (Nov 21, 2024)
Clue by Biowink
Germany
- Berlin
- 16/12/2021
- Series B
- $17,984,000
Clue is the #1 doctor-recommended period & cycle tracking app available on iOS, Android, and Apple Watch. Across the globe, more than 10 million active users rely on Clue to help understand their bodies better and keep their data safe and private.
Clue’s mission is for women and people with cycles to make good choices for themselves, and live full lives not in spite of their biology, but in tune with it. Clue was founded in 2012 by a Danish female entrepreneur, Ida Tin, who is convinced that technology will profoundly change the future of family planning.
The app calculates and predicts users’ periods and PMS based on users’ data and calculates fertility windows based on global averages, which can be made more accurate by users’ entering ovulation test data. Their newest offering, Clue Plus, aims to make Clue accessible to as many people as possible around the world at only one euro (or the local currency equivalent) per month. Clue Plus offers enhanced Analysis and personalized predictions for cycle-related symptoms with Forecast.
Clue launched helloclue.com in February 2018 to help close the knowledge gap about the menstrual cycle—with information that’s accessible, serious, scientific, and empathetic.
Numerous major media have greatly praised Clue, including TechCrunch (“Clue is the most underrated app ever”), BuzzFeed, Wired (“Hottest Startups 2015”), Cosmopolitan (“We love Clue”) and The Huffington Post (“Awesome”).
The Berlin-based startup has the backing of prestigious investors such Union Square Ventures; Mosaic Ventures; Groupe Arnault, the controlling shareholder of LVMH Moët Hennessy - Louis Vuitton; Brigitte Mohn of Bertelsmann; and entrepreneurs from Spotify, SoundCloud and Dropbox.
- Industry Wellness and Fitness Services
- Website https://helloclue.com/
- LinkedIn https://www.linkedin.com/company/clue-by-biowink/
Related People
Ida TinCo Founder
Germany -
Berlin Metropolitan Area
Summary:
Ida Tin is the co-founder and CEO of Clue, the most trusted female health app. Clue enables women and people with menstrual cycles to make good choices for themselves and live full lives not in spite of their biology but in tune with it.
Clue has more than twelve million active users in over 190 countries, and is one of the most popular apps in the “Health & Fitness” category in the United States, Germany, the UK, Brazil, France, Mexico and many others.
Clue’s mission is to help people all around the world benefit from insights into female health. A lifelong entrepreneur and a modern feminist, Ida is convinced that technology will profoundly change the future of family planning.
Ida has been interviewed or featured in major media including The New York Times, New York Magazine, Forbes, Der Spiegel and Le Figaro. She was also a speaker at prestigious conferences such as TechCrunch Disrupt in San Francisco, LeWeb in Paris, Slush in Finland and many more.
Before starting Clue, Ida led motorcycle tours around the world in the motorcycle touring company MotoMundo she cofounded with her dad Hjalte Tin. She wrote a book about her travel adventures, “Directress”, that became a Danish bestseller and received rave reviews. As a child Ida grew up travelling the world on motorcycles with her parents and older brother.
Ida attended various art schools in South Africa and London, and graduated in 2004 from the progressive social entrepreneurship BA level business school The KaosPilots in Denmark. Ida currently lives in Berlin with her partner Hans, who also co-founded Clue, and their two small children.
Four Growers, Inc. | $9,000,000 | (Nov 21, 2024)
Flywl | $7,000,000 | (Nov 21, 2024)
StoreCash | $3,700,000 | (Nov 21, 2024)
Magma Math | $40,000,000 | (Nov 21, 2024)
Prompt Security | $18,000,000 | (Nov 21, 2024)
Qminder | $3,164,550 | (Nov 21, 2024)
Konsileo | $10,122,225 | (Nov 21, 2024)
BrightAI | $15,000,000 | (Nov 21, 2024)
Valora Therapeutics, Inc. | $30,000,000 | (Nov 21, 2024)